CryoVein saphenous vein is a valuable vascular option for cardiac and vascular surgeons when suitable autologous vasculature is not available.  When the patients own autologous tissue may not be an option, CryoVein is the alternative.  CryoLife's dedication to quality and a supportive clinical experience has made CryoVein the natural choice for cardiac and vascular bypass procedures for the past 20 years.

Time is of the essence when dealing with complications of limb threatening peripheral artery disease.  The commercial availability of cryopreserved saphenous vein has given CryoLife the ability to offer surgeons and their patients the critical key to limb salvage - a chance for more time.  Cryopreserved saphenous vein has demonstrated exceptional performance in below the knee bypass patients where synthetic materials have historically performed poorly.

CryoVein has a long history of providing revascularization options to those with no other alternative, giving patients a chance to clear lower limb infections and regain utilization.  Without the limb saving alternative offered by the cryopreserved saphenous vein, many patients only alternative is amputation.  CryoVein has given surgeons and their patients the option of time when they need it most.